CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 10, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

Mallinckrodt intiates retrospective study for inhaled therapy in COVID-19

admin - 0
 Nov. 10, 2020: Mallinckrodt plc, a global biopharmaceutical company announced initiation of a retrospective chart review study, titled "Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)"...

Pfizer announces positive results from fifth phase 3 trial of Abrocitinib

admin - 0
November 11, 2020: "Pfizer announced positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral...

CDC Investigation Notice: CDC investigating outbreak of E. coli infections

admin - 0
November 10, 2020: "A CDC Investigation Notice regarding a multistate outbreak of E. coli 0157:H7 infections has been posted. Key points: Twelve people infected with the outbreak strain of E....

Lilly Announces Webcast to Provide an Overview of Tirzepatide Phase 3 clinical program

admin - 0
November 11, 2020: Eli Lilly and Company will conduct a webcast on Friday, November 20, 2020 to provide an overview of the tirzepatide Phase 3 type 2...

AZ and Amgen announced results from NAVIGATOR Phase III trial for tezepelumab

admin - 0
November 10, 2020: AstraZeneca and Amgen today announced positive results from the NAVIGATOR Phase III trial for the potential new medicine tezepelumab in patients...

PFIZER ANNOUNCES PHASE 3 STUDY RESULTS FOR XELJANZ ® IN ANKYLOSING SPONDYLITIS

admin - 0
November 06, 2020: Pfizer announced positive results from a Phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active...

PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19

admin - 0
"Based on current projections we expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in...

ViiV Healthcare’s cabotegravir is superior to oral standard for HIV prevention in women

admin - 0
November 09, 2020: ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders,...

Calquence approved in the EU for the treatment of chronic lymphocytic leukaemia

admin - 0
November 09, 2020: AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union (EU) for the treatment of...

Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis

admin - 0
 November 5, 2020:Novartis, a leader in rheumatology and immuno-dermatology, today announced 12-week results from the first-of-its-kind Phase IIIb ULTIMATE randomized controlled trial, which demonstrated...

Forxiga approved in the EU for heart failure

admin - 0
November 05, 2020: AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction...

Sobi launches thrombocytopenia drug Doptelet (avatrombopag) in EU

admin - 0
November 04, 2020: "Sobi announced the commercial launch of Doptelet® (avatrombopag) in Europe, with the United Kingdom as the first country for launch. Doptelet...
1...678...65Page 7 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved